Clin2
NCT06985875Possibly a fitNot yet recruiting

Testing a new eye drop for dry eye relief

Eye Dryness

Part of Eyes & vision clinical trials.

This trial tests a new eye drop, Drop 0.4%, for people with dry eye. It includes both people who wear contact lenses and those who don’t, to see if the drop is safe and helps with symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
79 people
Ages
18 years to 99 years
Study type
Interventional

Who can take part

  • You must be 18 or older.
  • You must have dry eye symptoms, measured by a questionnaire.
  • You cannot have other active eye diseases or severe dry eye.
  • You must avoid certain eye medications and surgeries before and during the study.
  • If you wear contact lenses, you must use them at least 4 days a week and 4 hours a day.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07625124Not yet recruiting· Phase 2
Testing a new eye drop for dry eye disease

This study tests whether RCI001, a new eye drop treatment, can help people with dry eye disease. If you've had dry eye symptoms for at least 6 months and are interested in trying a new treatment, this trial may be for you.

NCT07593404Recruiting
Testing a New Eye Drop for Dry Eye Disease

This study tests a new lubricating eye drop designed to relieve dry eye symptoms. If you have dry eye disease, this trial may help determine if the new formula works better than what's currently available.

Waterloo, Ontario
NCT07503886Recruiting· Phase 2
Study of an eye drop for dry eye disease

This trial tests a new eye drop called DFL24498 to see if it helps people with dry eye disease. You may qualify if your dry eye is moderate to severe and other treatments haven't worked well for you.

Chandler, Arizona
NCT07369375Not yet recruiting
Testing New Eye Drops for Dry Eye Disease

This study tests new eye drops for people with mild to moderate dry eye disease. It will check how well the drops work and if they are safe over time.

NCT06375343Not yet recruiting· Phase 1
Testing a new artificial tear versus Optive in healthy adults

This trial tests a new eye drop called PRO-240 versus Optive artificial tears in healthy adults. You will attend several visits over a few weeks and use the assigned drops as directed. The goal is to see if the new drop is as safe and comfortable as the standard one.

NCT07068958Not yet recruiting· Phase 2
A study testing a new eye drop for dry eye

This trial tests a new eye drop called RCI001 to see if it works better than a placebo for people with dry eye. You may be able to join if you have had dry eye for at least 6 months and have certain signs of dry eye during exams.

Hear when a new Eye Dryness trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.